Compare MPLT & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPLT | ARI |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2025 | 2009 |
| Metric | MPLT | ARI |
|---|---|---|
| Price | $13.34 | $6.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $32.67 | $11.00 |
| AVG Volume (30 Days) | 572.6K | ★ 2.6M |
| Earning Date | 05-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 9.31% |
| EPS Growth | 82.39 | ★ 183.51 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $271,589,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $25.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.10 | $6.43 |
| 52 Week High | $40.43 | $11.24 |
| Indicator | MPLT | ARI |
|---|---|---|
| Relative Strength Index (RSI) | 39.90 | 38.71 |
| Support Level | $12.24 | $6.43 |
| Resistance Level | $20.20 | $7.00 |
| Average True Range (ATR) | 0.94 | 0.10 |
| MACD | 0.89 | 0.09 |
| Stochastic Oscillator | 76.10 | 40.00 |
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.